A systematic review of preclinical animal studies on fenofibrate’s potential role in type 1 diabetic micro-vascular complications
Abstract Fenofibrate is a peroxisome-proliferator-activator α agonist and it is a widely used drug for hyperlipidemia since its approval in 2004. So, in this review we are focusing on the effect of fenofibric acid’s mechanism to alleviate type 1 diabetic micro vascular complications like diabetic re...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidade de São Paulo
2023-01-01
|
Series: | Brazilian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502022000100867&tlng=en |